Thermo Fisher Scientific RRBP1 Monoclonal Antibody (P5610)

Applications

Tested Dilution

Publications

Western Blot (WB)

1:500-1:3,000

-

Immunocytochemistry (ICC/IF)

1:100-1:2,000

-

Product Specifications

Species Reactivity

Human

Host/Isotype

Mouse / IgG2a

Class

Monoclonal

Type

Antibody

Clone

P5610

Immunogen

Recombinant fragment corresponding to a region within amino acids 750 and 977 of Ribosome binding protein 1 if (typeof window.$mangular === undefined || !window.$mangular) { window.$mangular = {}; } $mangular.antigenJson = \[{targetFamily:RRBP1,uniProtId:Q9P2E9-1,ncbiNodeId:9606,antigenRange:750-977,antigenLength:1410,antigenImageFileName:MA5-18302_RRBP1_Q9P2E9-1_House_mouse.svg,antigenImageFileNamePDP:MA5-18302_RRBP1_Q9P2E9-1_House_mouse_PDP.jpeg,sortOrder:1}\]; $mangular.isB2BCMGT = false; $mangular.isEpitopesModalImageMultiSizeEnabled = true;

View immunogen .st0{fill:#FFFFFF;} .st1{fill:#1E8AE7;}

Conjugate

Unconjugated Unconjugated Unconjugated

Form

Liquid

Concentration

1 mg/mL

Purification

Protein G

Storage buffer

PBS

Contains

no preservative

Storage conditions

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

RRID

AB_2539676

Product Specific Information

Recommended positive controls: HepG2.

Predicted reactivity: Mouse (81%), Dog (83%).

Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.

Target Information

Analysis of cDNA clones indicates that ribosome binding protein 1 may exist in different forms due to removal of tandem repeats, or partial intraexonic splicing of RRBP1. The form presented here is lacking the canine p180 ribosome-binding domain, NQGKKAEGAQ, which is tandemly repeated close to the N-terminus in other forms that haven`t been fully characterized. RRBP1 has been excluded as a candidate gene in the cause of Alagille syndrome. Alternate splicing results in multiple transcript variants.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.